论文部分内容阅读
目的观察纤维支气管镜介入治疗耐多药肺结核并支气管结核的疗效。方法204例耐多药肺结核并支气管结核患者随机分为治疗组与对照组。治疗组在常规化疗的基础上根据不同情况每周一次纤支镜介入治疗;对照组单纯化疗。结果治疗组18个月后,痰菌阴转率为73.7%;纤支镜改善总有效率为68.7%;肺不张复张总有效率为66.7%;胸片病灶吸收总有效率为72.7%。结论纤维支气管镜介入治疗耐多药肺结核并支气管结核是一种安全的方法且临床效果好。
Objective To observe the therapeutic effects of bronchofibroscopes on multidrug-resistant pulmonary tuberculosis and bronchial tuberculosis. Methods 204 patients with MDR-TB and bronchial tuberculosis were randomly divided into treatment group and control group. On the basis of routine chemotherapy, the treatment group was treated with interventional bronchoscopy once a week according to different situations; the control group was treated with chemotherapy alone. Results 18 months after treatment, sputum negative conversion rate was 73.7%; bronchoscopy improved the total effective rate was 68.7%; atelectasis total effective rate was 66.7%; chest X-ray absorption of the total effective rate was 72.7% . Conclusion The interventional therapy of bronchofibroscopes with multi-drug resistant pulmonary tuberculosis and bronchial tuberculosis is a safe method and has good clinical effect.